Prion infection promotes extensive accumulation of α-synuclein in aged human α-synuclein transgenic mice

Prion

Volumn 6, Issue 2, 2012, Pages 184-190

  Masliah, Eliezer ^a,b   Rockenstein, Edward ^a   Inglis, Chandra ^a   Adame, Anthony ^a   Bett, Cyrus ^b   Lucero, Melanie ^b   Sigurdson, Christina J ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Amyloid; Neurodegeneration; Plaque; Prion; Strain; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; PRION PROTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; INOCULATION; MOUSE; NONHUMAN; PRION DISEASE; PROTEIN AGGREGATION; SCRAPIE; SENILE PLAQUE; SYNAPSE; TRANSGENIC MOUSE;

AGING; ALPHA-SYNUCLEIN; AMYLOID; ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PRPSC PROTEINS; SCRAPIE;

MUS; MUS MUSCULUS;

EID: 84861761076     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.19806     Document Type: Conference Paper

References (39)

1. Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004; 10:1055-63. (Pubitemid 39424865)
2. Lansbury PT, Lashuel HA. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 2006; 443:774-9. (Pubitemid 44622681)
3. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, et al. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 2001; 98:12245-50. (Pubitemid 32959858)
4. Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, et al. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS One 2008; 3:3135.
5. Small SA, Duff K. Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 2008; 60:534-42.
6. Head MW, Lowrie S, Chohan G, Knight R, Scoones DJ, Ironside JW. Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, alpha synuclein and Abeta pathology. Acta Neuropathol 2010; 120:821-3.
7. Harper JD, Lansbury PT Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997; 66:385-407. (Pubitemid 27274662)
8. Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003; 300:636-40. (Pubitemid 36520587)
9. Schmidt ML, Martin JA, Lee VM, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996; 91:475-81.
10. Marui W, Iseki E, Ueda K, Kosaka K. Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease. J Neurol Sci 2000; 174:81-4. (Pubitemid 30155896)
11. Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, et al. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci 2010; 30:4528-35.
12. Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89:1105-52.
13. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44. (Pubitemid 12089840)
14. Hadlow WJ. Neuropathology and the scrapie-kuru connection. Brain Pathol 1995; 5:27-31.
15. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, et al. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 2002; 322:1089-102. (Pubitemid 35266514)
16. Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, et al. In vivo demonstration that alphasynuclein oligomers are toxic. Proc Natl Acad Sci USA 2011; 108:4194-9.
17. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neurona cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 2009; 106:13010-5.
18. Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 2010; 285:9262-72.
19. Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 2010; 6:702-6.
20. Haik S, Privat N, Adjou KT, Sazdovitch V, Dormont D, Duyckaerts C, et al. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases. Acta Neuropathol (Berl) 2002; 103:516-20. (Pubitemid 36075349)
21. Adjou KT, Allix S, Ouidja MO, Backer S, Couquet C, Cornuejols MJ, et al. Alpha-synuclein accumulates in the brain of scrapie-affected sheep and goats. J Comp Pathol 2007; 137:78-81. (Pubitemid 47044753)
22. Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19:8866-75. (Pubitemid 30226708)
23. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, et al. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995; 14:467-75.
24. Mougenot AL, Bencsik A, Nicot S, Vulin J, Morignat E, Verchere J, et al. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated alpha-synuclein. J Neuropathol Exp Neurol 2011; 70:377-85.
25. Rodriguez-Diehl R, Rey MJ, Gironell A, Martinez-Saez E, Ferrer I, Sanchez-Valle R, et al. "Preclinical" MSA in definite Creutzfeldt-Jakob disease. Neuropathology.
26. Yoshida H, Terada S, Ishizu H, Ikeda K, Hayabara T, Deguchi K, et al. An autopsy case of Creutzfeldt-Jakob disease with a V180I mutation of the PrP gene and Alzheimer-type pathology. Neuropathology 2010; 30:159-64.
27. Debatin L, Streffer J, Geissen M, Matschke J, Aguzzi A, Glatzel M. Association between deposition of betaamyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener Dis 2008; 5:347-54.
28. Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 2002; 68:568-78. (Pubitemid 34575622)
29. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 1998; 4:1318-20. (Pubitemid 28512115)
30. Lim Y, Kehm VM, Li C, Trojanowski JQ, Lee VM. Forebrain overexpression of alpha-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption. Exp Neurol 2009; 221:86-97.
31. Asuni AA, Hilton K, Siskova Z, Lunnon K, Reynolds R, Perry VH, et al. Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease. Neuroscience 2010; 165:662-74.
32. Lopez CD, Yost CS, Prusiner SB, Myers RM, Lingappa VR. Unusual topogenic sequence directs prion protein biogenesis. Science 1990; 248:226-9.
33. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998; 279:827-34. (Pubitemid 28106269)
34. Jiang P, Gan M, Ebrahim AS, Lin WL, Melrose HL, Yen SH. ER stress response plays an important role in aggregation of alpha-synuclein. Mol Neurodegener 2010; 5:56.
35. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrPres (PrP(Sc)) into contiguous membranes. EMBO J 2002; 21:1031-40. (Pubitemid 34206176)
36. Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH. Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 2004; 24:6715-23. (Pubitemid 38993891)
37. Masliah E, Rockenstein E. Genetically altered transgenic models of Alzheimer's disease. J Neural Transm Suppl 2000; 59:175-83. (Pubitemid 30479418)
38. Magen I, Chesselet MF. Genetic mouse models of Parkinson's disease The state of the art. Prog Brain Res 2010; 184:53-87.
39. Polymenidou M, Moos R, Scott M, Sigurdson C, Shi YZ, Yajima B, et al. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS ONE 2008; 3:3872.